gemcitabine
Showing 26 - 50 of 1,157
Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)
Recruiting
- Breast Cancer
- Breast Neoplasms
- Gemcitabine
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
May 17, 2022
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)
Not yet recruiting
- Pancreas Cancer
- Gemcitabine
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Aug 15, 2022
Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
- CT-707
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 17, 2022
Locally Advanced Pancreatic Cancer Trial in Guangzhou (Sulfatinib, Serplulimab, Albumin-paclitaxel)
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Sulfatinib
- +3 more
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Aug 10, 2023
Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)
Recruiting
- Advanced Biliary Tract Cancer
- Envofolimab
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022
Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)
Not yet recruiting
- Borderline Resectable Carcinoma
- Biliary Tract Cancer
- Durvalumab
- +4 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023
Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)
Not yet recruiting
- Soft Tissue Sarcoma
- +5 more
- Ascorbate
- Gemcitabine
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Sep 16, 2022
Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)
Recruiting
- Non-muscle-invasive Bladder Cancer
- BCG
- Gemcitabine
-
Cairo, EgyptMohamed Fawzy Salman
Nov 19, 2022
Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Recurrent or Metastatic
- KL-A167
- +3 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,
Completed
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- CEND-1
- +2 more
-
Woodville South, South Australia, Australia
- +2 more
Oct 26, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
- LY2880070
- Gemcitabine
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Locally Advanced Pancreatic Cancer Trial in Washington, Baltimore (Gemcitabine, Hypofractionated Ablative Proton Therapy)
Recruiting
- Locally Advanced Pancreatic Cancer
- Gemcitabine
- Hypofractionated Ablative Proton Therapy
-
Washington, District of Columbia
- +1 more
Oct 10, 2022
Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)
Active, not recruiting
- Pancreatic Ductal Adenocarcinoma
- BMS-813160
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 8, 2022
Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)
Active, not recruiting
- Pancreatic Adenocarcinoma
- 9-ING-41
- +3 more
-
Fairway, KansasKansas University Cancer center
Nov 2, 2022
Pancreatic Adenocarcinoma, Metastatic Trial in Spain, United States (Nab-paclitaxel, Gemcitabine, VCN-01)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Metastatic
- Nab-paclitaxel
- +2 more
-
New York, New York
- +7 more
Jan 3, 2023
Small Cell Lung Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Winston-Salem (Gemcitabine,
Completed
- Small Cell Lung Carcinoma
- +3 more
- Gemcitabine
- Nivolumab
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Sep 6, 2022
LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)
Suspended
- LMS - Leiomyosarcoma
- Uterine Leiomyosarcoma
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University
Oct 24, 2022
Triple Negative Breast Cancer Trial in Shanghai (Gemcitabine, Cisplatin)
Active, not recruiting
- Triple Negative Breast Cancer
- Gemcitabine
- Cisplatin
-
Shanghai, Shanghai, ChinaCancer Hospital/ Institute, Fudan University
Jul 19, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023
Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)
Recruiting
- Pancreatic Neoplasms
- Penpulimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022
Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)
Not yet recruiting
- Serous Ovarian Cancer
- Advanced Ovarian Cancer
- SC0191
- +2 more
- (no location specified)
Sep 20, 2023